Cataract surgery induces retinal pro-inflammatory gene expression and protein secretion

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 1, 2011, Pages 249-255

  Xu, Heping ^a   Chen, Mei ^a   Forrester, John V ^a   Lois, Noemi ^b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT MEMBRANE ATTACK COMPLEX; FIBROBLAST GROWTH FACTOR; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA; COMPLEMENT; CXCL12 PROTEIN, HUMAN; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATARACT EXTRACTION; CHOROID; COMPLEMENT ACTIVATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EXTRACAPSULAR CATARACT EXTRACTION; GENE EXPRESSION; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; INJURY; MALE; MOUSE; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; RETINITIS; ANIMAL; C57BL MOUSE; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; RETINA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CATARACT EXTRACTION; CHEMOKINE CCL2; CHEMOKINE CXCL12; CHOROID; COMPLEMENT SYSTEM PROTEINS; CYTOKINES; FIBROBLAST GROWTH FACTORS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION; INTERLEUKIN-1BETA; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; RETINA; RETINAL PIGMENT EPITHELIUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 79952224971     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-6001     Document Type: Article

References (56)

1. Borrillo JL, Mittra RA, Dev S, et al. Retinopathy progression and visual outcomes after phacoemulsification in patients with diabetes mellitus. Trans Am Ophthalmol Soc. 1999;97:435-445; discussion 445-449.
2. Kato S, Fukada Y, Hori S, Tanaka Y, Oshika T. Influence of phacoemulsification and intraocular lens implantation on the course of diabetic retinopathy. J Cataract Refract Surg. 1999;25:788-793.
3. Mittra RA, Borrillo JL, Dev S, Mieler WF, Koenig SB. Retinopathy progression and visual outcomes after phacoemulsification in patients with diabetes mellitus. Arch Ophthalmol. 2000;118:912-917.
4. Zaczek A, Olivestedt G, Zetterstrom C. Visual outcome after phacoemulsification and IOL implantation in diabetic patients. BrJ Ophthalmol. 1999;83:1036-1041.
5. Chew EY, Benson WE, Remaley NA, et al. Results after lens extraction in patients with diabetic retinopathy: early treatment diabetic retinopathy study report number 25. Arch Ophthalmol. 1999;117: 1600-1606.
6. Hong T, Mitchell P, de Loryn T, Rochtchina E, Cugati S, Wang JJ. Development and progression of diabetic retinopathy 12 months after phacoemulsification cataract surgery. Ophthalmology. 2009; 116:1510-1514.
7. Freeman EE, Munoz B, West SK, Tielsch JM, Schein OD. Is there an association between cataract surgery and age-related macular degeneration? Data from three population-based studies. Am J Ophthalmol. 2003;135:849-856.
8. Wang JJ, Klein R, Smith W, Klein BE, Tomany S, Mitchell P. Cataract surgery and the 5-year incidence of late-stage age-related maculopathy: pooled findings from the Beaver Dam and Blue Mountains Eye studies. Ophthalmology. 2003;110:1960-1967.
9. Klein BE. Is the risk of incidence or progression of age-related macular degeneration increased after cataract surgery? Arch Ophthalmol. 2009;127:1528-1529.
10. Dong LM, Stark WJ, Jefferys JL, et al. Progression of age-related macular degeneration after cataract surgery. Arch Ophthalmol. 2009;127:1412-1419.
11. Chew EY, Sperduto RD, Milton RC, et al. Risk of advanced agerelated macular degeneration after cataract surgery in the agerelated eye disease study: AREDS report 25. Ophthalmology. 2009; 116:297-303.
12. Cugati S, Mitchell P, Rochtchina E, Tan AG, Smith W, Wang JJ. Cataract surgery and the 10-year incidence of age-related maculopathy: the Blue Mountains Eye Study. Ophthalmology. 2006;113:2020-2025.
13. Seigel D. Cataract surgery and macular degeneration progression. Ophthalmology. 2009;116:2482-2483; author reply 2483.
14. Irvine SR. A newly defined vitreous syndrome following cataract surgery. Am J Ophthalmol. 1953;36:499-619.
15. Gass JD, Norton EW. Cystoid macular edema and papilledema following cataract extraction. A fluorescein fundoscopic and angiographic study. Arch Ophthalmol. 1966;76:646-661.
16. Tso MO, Shih CY. Experimental macular edema after lens extraction. Invest Ophthalmol Vis Sci. 1977;16:381-392.
17. Liu H, Demetriades AM, Xiao WH, Campochiaro PA, Vinores SA. Mouse model of post-surgical breakdown of the blood-retinal barrier. Curr Eye Res. 2004;28:421-426.
18. Lois N, Dawson R, McKinnon AD, Forrester JV. A new model of posterior capsule opacification in rodents. Invest Ophthalmol Vis Sci. 2003;44:3450-3457.
19. Lois N, Taylor J, McKinnon AD, Forrester JV. Posterior capsule opacification in mice. Arch Ophthalmol. 2005;123:71-77.
20. Chen M, Muckersie E, Robertson M, Forrester JV, Xu H. Upregulation of complement factor B in retinal pigment epithelial cells is accompanied by complement activation in the aged retina. Exp Eye Res. 2008;87:543-550.
21. Xu H, Chen M, Forrester JV. Para-inflammation in the aging retina. Prog Retin Eye Res. 2009;28:348-368.
22. Zipfel PF, Skerka C. Complement regulators and inhibitory proteins. Nat Rev Immunol. 2009;9:729-740.
23. Netea MG, Simon A, van de Veerdonk F, Kullberg BJ, Van der Meer JW, Joosten LA. IL-1beta processing in host defense: beyond the inflammasomes. PLoS Pathog. 2010;6:e1000661.
24. Lois N, Dawson R, Townend J, et al. Effect of short-term macrophage depletion in the development of posterior capsule opacification in rodents. Br J Ophthalmol. 2008;92:1528-1533.
25. Kono H, Chen CJ, Ontiveros F, Rock KL. Uric acid promotes an acute inflammatory response to sterile cell death in mice. J Clin Invest. 2010;120:1939-1949.
26. Kono H, Karmarkar D, Iwakura Y, Rock KL. Identification of the cellular sensor that stimulates the inflammatory response to sterile cell death. J Immunol. 2010;184:4470-4478.
27. Bamforth SD, Lightman SL, Greenwood J. Interleukin-1 beta-induced disruption of the retinal vascular barrier of the central nervous system is mediated through leukocyte recruitment and histamine. Am J Pathol. 1997;150:329-340.
28. Claudio L, Martiney JA, Brosnan CF. Ultrastructural studies of the blood-retina barrier after exposure to interleukin-1 beta or tumor necrosis factor-alpha. Lab Invest. 1994;70:850-861.
29. Cuff CA, Berman JW, Brosnan CF. The ordered array of perivascular macrophages is disrupted by IL-1-induced inflammation in the rabbit retina. Glia. 1996;17:307-316.
30. Vincent JA, Mohr S. Inhibition of caspase-1/interleukin-1beta signaling prevents degeneration of retinal capillaries in diabetes and galactosemia. Diabetes. 2007;56:224-230.
31. Kowluru RA, Odenbach S. Role of interleukin-1beta in the pathogenesis of diabetic retinopathy. Br J Ophthalmol. 2004;88:1343-1347.
32. Saishin Y, Saishin Y, Takahashi K, Melia M, Vinores SA, Campochiaro PA. Inhibition of protein kinase C decreases prostaglandin- induced breakdown of the blood-retinal barrier. J Cell Physiol. 2003;195:210-219.
33. Vinores SA, Xiao WH, Zimmerman R, Whitcup SM, Wawrousek EF. Upregulation of vascular endothelial growth factor (VEGF) in the retinas of transgenic mice overexpressing interleukin-1beta (IL- 1beta) in the lens and mice undergoing retinal degeneration. Histol Histopathol. 2003;18:797-810.
34. Anderson DH, Radeke MJ, Gallo NB, et al. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res. 2010;29: 95-112.
35. Zhang J, Gerhardinger C, Lorenzi M. Early complement activation and decreased levels of glycosylphosphatidylinositol-anchored complement inhibitors in human and experimental diabetic retinopathy. Diabetes. 2002;51:3499-3504.
36. Yang Y, Lu HL, Zhang J, et al. Relationships among acylation stimulating protein, adiponectin and complement C3 in lean vs obese type 2 diabetes. Int J Obes (Lond). 2006;30:439-446.
37. Wang J, Ohno-Matsui K, Yoshida T, et al. Amyloid-beta up-regulates complement factor B in retinal pigment epithelial cells through cytokines released from recruited macrophages/microglia: another mechanism of complement activation in age-related macular degeneration. J Cell Physiol. 2009;220:119-128.
38. Rollins BJ. Monocyte chemoattractant protein, 1: a potential regulator of monocyte recruitment in inflammatory disease. Mol Med Today. 1996;2:198-204.
39. Crane IJ, Wallace CA, McKillop-Smith S, Forrester JV. Control of chemokine production at the blood-retina barrier. Immunology. 2000;101:426-433.
40. Elner SG, Strieter RM, Elner VM, Rollins BJ, Del Monte MA, Kunkel SL. Monocyte chemotactic protein gene expression by cytokinetreated human retinal pigment epithelial cells. Lab Invest. 1991; 64:819-825.
41. Chen M, Muckersie E, Robertson M, Fraczek M, Forrester JV, Xu H. Characterization of a spontaneous mouse retinal pigment epithelial cell line B6-RPE07. Invest Ophthalmol Vis Sci. 2008;49:3699-3706.
42. Holtkamp GM, De Vos AF, Peek R, Kijlsta A. Analysis of the secretion pattern of monocyte chemotactic protein-1 (MCP-1) and transforming growth factor-beta 2 (TGF-beta2) by human retinal pigment epithelial cells. Clin Exp Immunol. 1999;118:35-40.
43. Blaauwgeers HG, Holtkamp GM, Rutten H, et al. Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris: evidence for a trophic paracrine relation. Am J Pathol. 1999;155:421-428.
44. Ambati J, Anand A, Fernandez S, et al. An animal model of agerelated macular degeneration in senescent ccl-2- or ccr-2-deficient mice. Nat Med. 2003;9:1390-1397.
45. Sen HN, Nussenblatt RB. Sympathetic ophthalmia: what have we learned? Am J Ophthalmol. 2009;148:632-633.
46. Du L, Kijlstra A, Yang P. Immune response genes in uveitis. Ocul Immunol Inflamm. 2009;17:249-256.
47. Yamaki K, Ohono S. Animal models of Vogt-Koyanagi-Harada disease (sympathetic ophthalmia). Ophthalmic Res. 2008;40:129-135.
48. El-Asrar AM, Al-Obeidan SA. Sympathetic ophthalmia after complicated cataract surgery and intraocular lens implantation. Eur J Ophthalmol. 2001;11:193-196.
49. Auw-Haedrich C, Loeffler KU, Witschel H. Sympathetic ophthalmia: an immunohistochemistry study of four cases. Ger J Ophthalmol. 1996;5:98-103.
50. Lakhanpal V, Dogra MR, Jacobson MS. Sympathetic ophthalmia associated with anterior chamber intraocular lens implantation. Ann Ophthalmol. 1991;23:139-143.
51. Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol. 2009;27:229-265.
52. Gris D, Ye Z, Iocca HA, et al. NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses. J Immunol. 2010;185:974-981.
53. Forrester JV, Worgul BV, Merriam GR Jr. Endotoxin-induced uveitis in the rat. Albrecht von Graefes Arch Klin Exp Ophthalmol. 1980;213:221-233.
54. Heier JS, Topping TM, Baumann W, Dirks MS, Chern S. Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema. Ophthalmology. 2000;107:2034-2038; discussion 2039.
55. Benhamou N, Massin P, Haouchine B, Audren F, Tadayoni R, Gaudric A. Intravitreal triamcinolone for refractory pseudophakic macular edema. Am J Ophthalmol. 2003;135:246-249.
56. Wittpenn JR, Silverstein S, Heier J, et al. A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients. Am J Ophthalmol. 2008;146: 554-560.